These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24815311)

  • 1. Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light.
    Salmani JM; Asghar S; Lv H; Zhou J
    Molecules; 2014 May; 19(5):5925-39. PubMed ID: 24815311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-formulation and chemical stability studies of penethamate, a benzylpenicillin ester prodrug, in aqueous vehicles.
    Jain R; Wu Z; Bork O; Tucker IG
    Drug Dev Ind Pharm; 2012 Jan; 38(1):55-63. PubMed ID: 21696334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a lyophilised RH1 formulation: a novel DT diaphorase activated alkylating agent.
    Elliott MA; Ford SJ; Walker AA; Hargreaves RH; Halbert GW
    J Pharm Pharmacol; 2002 Apr; 54(4):487-92. PubMed ID: 11999125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubility Determination, Hansen Solubility Parameters and Thermodynamic Evaluation of Thymoquinone in (Isopropanol + Water) Compositions.
    Ghazwani M; Begum MY; Alam P; Alqarni MH; Yusufoglu HS; Shakeel F
    Molecules; 2021 May; 26(11):. PubMed ID: 34073527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone I: Kinetics in aqueous solutions by high-performance liquid chromatography.
    Poochikian GK; Cradock JC
    J Pharm Sci; 1981 Feb; 70(2):159-62. PubMed ID: 7205219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
    Denora N; Potts BC; Stella VJ
    J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and degradation profiles of Spantide II in aqueous solutions.
    Kikwai L; Babu RJ; Kanikkannan N; Singh M
    Eur J Pharm Sci; 2006 Feb; 27(2-3):158-66. PubMed ID: 16266798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation kinetics of metronidazole in solution.
    Wang DP; Yeh MK
    J Pharm Sci; 1993 Jan; 82(1):95-8. PubMed ID: 8429500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoquinone-Loaded Soluplus
    Bergonzi MC; Vasarri M; Marroncini G; Barletta E; Degl'Innocenti D
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photostability of 2-hydroxymethyl-4,8-dibenzo[1,2-b:5,4-b']dithiophene-4,8-dione (NSC 656240), a potential anticancer drug.
    Silchenko S; Schöneich C; Carlson BJ; Stella VJ
    Int J Pharm; 2003 Oct; 264(1-2):97-105. PubMed ID: 12972339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone-based nanotechnology for cancer therapy: promises and challenges.
    Ballout F; Habli Z; Rahal ON; Fatfat M; Gali-Muhtasib H
    Drug Discov Today; 2018 May; 23(5):1089-1098. PubMed ID: 29374534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M.
    Krishna G; Hodnick WF; Lang W; Lin X; Karra S; Mao J; Almassian B
    AAPS PharmSciTech; 2001 Aug; 2(3):E14. PubMed ID: 14727873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions.
    Prajapati M; Eiriksson FF; Loftsson T
    Int J Pharm; 2020 Aug; 586():119579. PubMed ID: 32599134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hydrochemistry variables on the half-life of mancozeb and on the hazard index associated to the sum of mancozeb and ethylenethiourea.
    López-Fernández O; Pose-Juan E; Rial-Otero R; Simal-Gándara J
    Environ Res; 2017 Apr; 154():253-260. PubMed ID: 28110212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aqueous stability of bupropion.
    O'Byrne PM; Williams R; Walsh JJ; Gilmer JF
    J Pharm Biomed Anal; 2010 Nov; 53(3):376-81. PubMed ID: 20547024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionization.
    See E; Zhang W; Liu J; Svirskis D; Baguley BC; Shaw JP; Wang G; Wu Z
    Int J Pharm; 2014 Oct; 473(1-2):528-35. PubMed ID: 25079434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of human telomeric G-quadruplex DNA with thymoquinone: a possible mechanism for thymoquinone anticancer effect.
    Salem AA; El Haty IA; Abdou IM; Mu Y
    Biochim Biophys Acta; 2015 Feb; 1850(2):329-42. PubMed ID: 25450185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of urea in solution and pharmaceutical preparations.
    Panyachariwat N; Steckel H
    J Cosmet Sci; 2014; 65(3):187-95. PubMed ID: 25043489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
    Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
    Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles.
    Ganea GM; Fakayode SO; Losso JN; van Nostrum CF; Sabliov CM; Warner IM
    Nanotechnology; 2010 Jul; 21(28):285104. PubMed ID: 20585163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.